drugset / Trial / NCT07740577

Routine Antiemetic Prophylaxis for Nonfasted Parturients Undergoing Cesarean Sections Under Spinal Anesthesia

NCT07740577 ↗

Phase 4 Recruiting 120 enrolled Sanliurfa Education and Research Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of this prospective randomized double-blind study is to compare the effectiveness of routine antiemetic prophylaxis for the prevention of intraoperative nausea and vomiting (IONV) in non-fasted parturients undergoing emergency cesarean section under spinal anesthesia. Nausea and vomiting are common complications during cesarean delivery performed under spinal anesthesia and may negatively affect maternal comfort and perioperative safety. The incidence of these symptoms may be particularly increased in emergency cesarean sections involving non-fasted (full-stomach) parturients. This study compares two commonly used antiemetic strategies, namely 5-hydroxytryptamine-3 (5-HT3) receptor antagonists and dopamine receptor antagonists, to determine their relative effectiveness in preventing IONV during surgery. The findings are expected to contribute to optimization of antiemetic prophylaxis protocols, improvement of maternal comfort, and reduction of perioperative complications associated with nausea and vomiting during emergency cesarean delivery.

Timeline

Start
2026-07-30
Primary completion
2027-01-01
Completion
2027-01-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Metoclopramide Small molecule — Intravenous
Subject Ondansetron Other / unclassified 4 mg Intravenous

Indications

No indication recorded.